{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:59:04Z","timestamp":1785884344490,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R18-HS020002"],"award-info":[{"award-number":["R18-HS020002"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24-AI080942"],"award-info":[{"award-number":["K24-AI080942"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K01-AI103028"],"award-info":[{"award-number":["K01-AI103028"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K01-AI137317"],"award-info":[{"award-number":["K01-AI137317"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["FOA#CK000163"],"award-info":[{"award-number":["FOA#CK000163"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Antibacterial Resistance Leadership Group","award":["5 UM 1AI104681-05"],"award-info":[{"award-number":["5 UM 1AI104681-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3804-y","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T14:04:33Z","timestamp":1550153073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"name":"for the CDC Prevention Epicenters Program","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6671-4557","authenticated-orcid":false,"given":"Judith A.","family":"Anesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebbing","family":"Lautenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Nachamkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Garrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren B.","family":"Bilker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Omorogbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Dankwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Tolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"17","key":"3804_CR1","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1001\/archinte.158.17.1923","volume":"158","author":"L Simonsen","year":"1998","unstructured":"Simonsen L, Conn LA, Pinner RW, Teutsch S. Trends in infectious disease hospitalizations in the United States, 1980-1994. Arch Intern Med. 1998;158(17):1923\u20138.","journal-title":"Arch Intern Med"},{"issue":"9","key":"3804_CR2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1086\/592250","volume":"47","author":"DA Talan","year":"2008","unstructured":"Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ, Group EMINS. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis. 2008;47(9):1150\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3804_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dki166","volume":"56","author":"JD Pitout","year":"2005","unstructured":"Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1):52\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3804_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/jac\/dkl035","volume":"57","author":"E Calbo","year":"2006","unstructured":"Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 2006;57(4):780\u20133.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3804_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","volume":"23","author":"R Colodner","year":"2004","unstructured":"Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):163\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"3804_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ajic.2007.05.008","volume":"35","author":"A Apisarnthanarak","year":"2007","unstructured":"Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control. 2007;35(9):606\u201312.","journal-title":"Am J Infect Control"},{"issue":"7","key":"3804_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1086\/588082","volume":"29","author":"A Apisarnthanarak","year":"2008","unstructured":"Apisarnthanarak A, Kiratisin P, Mundy LM. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2008;29(7):671\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"3804_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","volume":"172","author":"MA Beerepoot","year":"2012","unstructured":"Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704\u201312.","journal-title":"Arch Intern Med"},{"issue":"1","key":"3804_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/2013.jamainternmed.829","volume":"173","author":"DM Drekonja","year":"2013","unstructured":"Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med. 2013;173(1):62\u20138.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"3804_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes. occurrence, recurrence, bacteriology, risk factors, and disease burden Infect Dis Clin North Am. 2014;28(1):1\u201313.","journal-title":"occurrence, recurrence, bacteriology, risk factors, and disease burden Infect Dis Clin North Am"},{"issue":"17","key":"3804_CR11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","volume":"168","author":"J Rodriguez-Bano","year":"2008","unstructured":"Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008;168(17):1897\u2013902.","journal-title":"Arch Intern Med"},{"key":"3804_CR12","unstructured":"CDC\/NHSN. CDC\/NHSN surveillance definitions for specific types of infections 2016. Available from: \n                    http:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf\n                    \n                  ."},{"key":"3804_CR13","unstructured":"Performance standards for antimicrobial susceptibility testing M100-S20. CLSI. 2010."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3804-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:41:26Z","timestamp":1589456486000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3804-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3804-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University of Pennsylvania\u2019s Institutional Review Board (Protocol 812302). Verbal informed consent was obtained from study participants, rather than written consent, because consent was obtained at the time of a follow-up phone call after the patient\u2019s clinical visit for the UTI. Written informed consent was not feasible since the patients were no longer in the clinic\/hospital when they were enrolled in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"163"}}